_version_ 1865920626631376896
author Caixas, Umbelina
author2 Ferreira, Joana
Marinho, Aline T.
Faustino, Inês
Grilo, Nádia M.
Lampreia, Fátima
Germano, Isabel
Monteiro, Emília C.
Monteiro, E.C.
Pereira, Sofia A.
SA, Pereira
author2_role author
author
author
author
author
author
author
author
author
author
author_facet Caixas, Umbelina
Caixas, Umbelina
Ferreira, Joana
Marinho, Aline T.
Faustino, Inês
Grilo, Nádia M.
Lampreia, Fátima
Germano, Isabel
Monteiro, Emília C.
Monteiro, E.C.
Pereira, Sofia A.
SA, Pereira
Ferreira, Joana
Marinho, Aline T.
Faustino, Inês
Grilo, Nádia M.
Lampreia, Fátima
Germano, Isabel
Monteiro, Emília C.
Monteiro, E.C.
Pereira, Sofia A.
SA, Pereira
author_role author
contributor_name_str_mv NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
Centro de Estudos de Doenças Crónicas (CEDOC)
British Society for Antimicrobial Chemotherapy | Oxford University Press
RUN
country_str PT
creators_json_str [{\"Person.name\":\"Caixas, Umbelina\"},{\"Person.name\":\"Ferreira, Joana\"},{\"Person.name\":\"Marinho, Aline T.\"},{\"Person.name\":\"Faustino, Inês\"},{\"Person.name\":\"Grilo, Nádia M.\"},{\"Person.name\":\"Lampreia, Fátima\"},{\"Person.name\":\"Germano, Isabel\"},{\"Person.name\":\"Monteiro, Emília C.\"},{\"Person.name\":\"Monteiro, E.C.\",\"Person.identifier.orcid\":\"0000-0002-0570-0765\"},{\"Person.name\":\"Pereira, Sofia A.\"},{\"Person.name\":\"SA, Pereira\",\"Person.identifier.orcid\":\"0000-0002-8456-9995\"}]
datacite.contributors.contributor.contributorName.fl_str_mv NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
Centro de Estudos de Doenças Crónicas (CEDOC)
British Society for Antimicrobial Chemotherapy | Oxford University Press
RUN
datacite.creators.creator.creatorName.fl_str_mv Caixas, Umbelina
Ferreira, Joana
Marinho, Aline T.
Faustino, Inês
Grilo, Nádia M.
Lampreia, Fátima
Germano, Isabel
Monteiro, Emília C.
Monteiro, E.C.
Pereira, Sofia A.
SA, Pereira
datacite.date.Accepted.fl_str_mv 2012-10-01T00:00:00Z
datacite.date.available.fl_str_mv 2023-12-28T22:11:05Z
datacite.date.embargoed.fl_str_mv 2023-12-28T22:11:05Z
datacite.rights.fl_str_mv http://purl.org/coar/access_right/c_abf2
datacite.subjects.subject.fl_str_mv CCR5 antagonists
HIV-2 CCR5 tropism
Persistent low CD4 cell count
Second-line HIV-2 therapy
Therapeutic drug monitoring
Pharmacology
Pharmacology (medical)
Infectious Diseases
SDG 3 - Good Health and Well-being
datacite.titles.title.fl_str_mv Long-term maraviroc use as salvage therapy in HIV-2 infection
dc.contributor.none.fl_str_mv NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
Centro de Estudos de Doenças Crónicas (CEDOC)
British Society for Antimicrobial Chemotherapy | Oxford University Press
RUN
dc.creator.none.fl_str_mv Caixas, Umbelina
Ferreira, Joana
Marinho, Aline T.
Faustino, Inês
Grilo, Nádia M.
Lampreia, Fátima
Germano, Isabel
Monteiro, Emília C.
Monteiro, E.C.
Pereira, Sofia A.
SA, Pereira
dc.date.Accepted.fl_str_mv 2012-10-01T00:00:00Z
dc.date.available.fl_str_mv 2023-12-28T22:11:05Z
dc.date.embargoed.fl_str_mv 2023-12-28T22:11:05Z
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv http://hdl.handle.net/10362/161711
dc.language.none.fl_str_mv eng
dc.rights.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.subject.none.fl_str_mv CCR5 antagonists
HIV-2 CCR5 tropism
Persistent low CD4 cell count
Second-line HIV-2 therapy
Therapeutic drug monitoring
Pharmacology
Pharmacology (medical)
Infectious Diseases
SDG 3 - Good Health and Well-being
dc.title.fl_str_mv Long-term maraviroc use as salvage therapy in HIV-2 infection
dc.type.none.fl_str_mv http://purl.org/coar/resource_type/c_6501
dirty 0
eu_rights_str_mv openAccess
format article
fulltext.url.fl_str_mv https://run.unl.pt/bitstreams/f88e4d9f-f017-45e3-9717-3b841e20953a/download
id run_ebb680bbc8b1ca4f0720d9b69c0b1397
identifier.url.fl_str_mv http://hdl.handle.net/10362/161711
instacron_str unl
institution Universidade Nova de Lisboa
instname_str Universidade Nova de Lisboa
language eng
network_acronym_str run
network_name_str Repositório Institucional da UNL
oai_identifier_str oai:run.unl.pt:10362/161711
organization_str_mv urn:organizationAcronym:unl
person_str_mv Caixas, Umbelina
Ferreira, Joana
Marinho, Aline T.
Faustino, Inês
Grilo, Nádia M.
Lampreia, Fátima
Germano, Isabel
Monteiro, Emília C.
Monteiro, E.C.
Monteiro, E.C.
https://www.ciencia-id.pt/5918-54A6-FAA0
5918-54A6-FAA0
http://orcid.org/0000-0002-0570-0765
0000-0002-0570-0765
Pereira, Sofia A.
SA, Pereira
SA, Pereira
https://www.ciencia-id.pt/6B13-7601-73A2
6B13-7601-73A2
http://orcid.org/0000-0002-8456-9995
0000-0002-8456-9995
publishDate 2012
reponame_str Repositório Institucional da UNL
repository_id_str urn:repositoryAcronym:run
service_str_mv urn:repositoryAcronym:run
spelling engapplication/pdfenLong-term maraviroc use as salvage therapy in HIV-2 infectionCaixas, UmbelinaFerreira, JoanaMarinho, Aline T.Faustino, InêsGrilo, Nádia M.Lampreia, FátimaGermano, IsabelMonteiro, Emília C.PersonalMonteiro, E.C.DSpacehttp://dspace.org/items/631292a4-58bc-4ec4-97ee-1143e44df2c0DSpacehttp://dspace.org/items/631292a4-58bc-4ec4-97ee-1143e44df2c0MonteiroEmília CarreiraCiência IDhttps://www.ciencia-id.pt5918-54A6-FAA0ORCIDhttp://orcid.org0000-0002-0570-0765Scopus Author IDhttps://www.scopus.com7102113853Pereira, Sofia A.PersonalSA, PereiraDSpacehttp://dspace.org/items/f4809377-832b-40b5-92ca-0bb1c6fe14f3DSpacehttp://dspace.org/items/f4809377-832b-40b5-92ca-0bb1c6fe14f3de Azeredo PereiraSofiaCiência IDhttps://www.ciencia-id.pt6B13-7601-73A2ORCIDhttp://orcid.org0000-0002-8456-9995Researcher IDhttps://www.researcherid.comM-2976-2019Scopus Author IDhttps://www.scopus.com35190948700Scopus Author IDhttps://www.scopus.com35190948700NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)Centro de Estudos de Doenças Crónicas (CEDOC)British Society for Antimicrobial Chemotherapy | Oxford University PressHostingInstitutionOrganizationalRUNe-mailmailto:run@unl.ptrun@unl.ptISSNIsPartOf0305-7453URNIsPartOfPURE: 5313000URNIsPartOfPURE UUID: 8d1ef3fe-1b80-4de8-aacc-91bed1bf09f5URNIsPartOfScopus: 84866613168URNIsPartOfPubMed: 22729923URNIsPartOfWOS: 000309140900042URNIsPartOfORCID: /0000-0002-8456-9995/work/59470824DOIIsPartOf10.1093/jac/dks2402023-12-28T22:11:05Z2012-10-012012-10-01T00:00:00ZHandlehttp://hdl.handle.net/10362/161711http://purl.org/coar/access_right/c_abf2open accessCCR5 antagonistsHIV-2 CCR5 tropismPersistent low CD4 cell countSecond-line HIV-2 therapyTherapeutic drug monitoringPharmacologyPharmacology (medical)Infectious DiseasesSDG 3 - Good Health and Well-being136184 bytesliteraturehttp://purl.org/coar/resource_type/c_6501journal articlehttp://purl.org/coar/access_right/c_abf2application/pdffulltexthttps://run.unl.pt/bitstreams/f88e4d9f-f017-45e3-9717-3b841e20953a/download
spellingShingle Long-term maraviroc use as salvage therapy in HIV-2 infection
Long-term maraviroc use as salvage therapy in HIV-2 infection
Caixas, Umbelina
CCR5 antagonists
HIV-2 CCR5 tropism
Persistent low CD4 cell count
Second-line HIV-2 therapy
Therapeutic drug monitoring
Pharmacology
Pharmacology (medical)
Infectious Diseases
SDG 3 - Good Health and Well-being
Caixas, Umbelina
CCR5 antagonists
HIV-2 CCR5 tropism
Persistent low CD4 cell count
Second-line HIV-2 therapy
Therapeutic drug monitoring
Pharmacology
Pharmacology (medical)
Infectious Diseases
SDG 3 - Good Health and Well-being
status NEW
subject.fl_str_mv CCR5 antagonists
HIV-2 CCR5 tropism
Persistent low CD4 cell count
Second-line HIV-2 therapy
Therapeutic drug monitoring
Pharmacology
Pharmacology (medical)
Infectious Diseases
SDG 3 - Good Health and Well-being
title Long-term maraviroc use as salvage therapy in HIV-2 infection
title_full Long-term maraviroc use as salvage therapy in HIV-2 infection
title_fullStr Long-term maraviroc use as salvage therapy in HIV-2 infection
Long-term maraviroc use as salvage therapy in HIV-2 infection
title_full_unstemmed Long-term maraviroc use as salvage therapy in HIV-2 infection
Long-term maraviroc use as salvage therapy in HIV-2 infection
title_short Long-term maraviroc use as salvage therapy in HIV-2 infection
title_sort Long-term maraviroc use as salvage therapy in HIV-2 infection
topic CCR5 antagonists
HIV-2 CCR5 tropism
Persistent low CD4 cell count
Second-line HIV-2 therapy
Therapeutic drug monitoring
Pharmacology
Pharmacology (medical)
Infectious Diseases
SDG 3 - Good Health and Well-being
topic_facet CCR5 antagonists
HIV-2 CCR5 tropism
Persistent low CD4 cell count
Second-line HIV-2 therapy
Therapeutic drug monitoring
Pharmacology
Pharmacology (medical)
Infectious Diseases
SDG 3 - Good Health and Well-being
url http://hdl.handle.net/10362/161711
visible 1